A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

A brief research report evaluated obesity among U.S. children and adolescents from 2011 to August 2023 and compared changes ...

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and ...

Discover how smoking during pregnancy may increase childhood obesity risk, according to new research from Washington State ...

Asian American and Pacific Islander (AAPI) adolescents with overweight or obesity are more than twice as likely to have ...

In a zebrafish model that mimics human obesity and craving behaviors, SKNY-1 demonstrated weight loss, suppression of appetite and craving for high-calorie diets, and reversal of nicotine-seeking ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

The study found body mass index (BMI) patterns that could predict obesity, with findings published in Jama Network Open.

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...